Chronic myeloid leukemia associated with early lymphoblastic crisis

dc.contributor.author	Katona, Timea
dc.contributor.author	Budeanu, Razvan-Gabriel
dc.contributor.author	Jugariu, Anamaria-Romina
dc.date.accessioned	2020-07-03T12:23:57Z
dc.date.available	2020-07-03T12:23:57Z
dc.date.issued	2018
dc.identifier.citation	KATONA, Timea, BUDEANU, Razvan-Gabriel, JUGARIU, Anamaria-Romina. Chronic myeloid leukemia associated with early lymphoblastic crisis. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 34-35.	en_US
dc.identifier.uri	https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
dc.identifier.uri	http://repository.usmf.md/handle/20.500.12710/10887
dc.description	University of Medicine and Pharmacy of Targu Mures, Romania	en_US
dc.description.abstract	Background. The blastic crisis of chronic myeloid leukemia (CML-BC) is usually the final phase of the disease, in which the percentage of the young, often undifferentiated cells, known as blastocytes gets above 20%. Nowadays, in the era of the therapy with Tyrosine Kinase Inhibitors, the transformation from CML to CML-BC occurs much later and more rarely.	en_US
dc.language.iso	en	en_US
dc.publisher	MedEspera	en_US
dc.subject	myeloid	en_US
dc.subject	leukemia	en_US
dc.subject	lymphoblastic	en_US
dc.subject	tyrosine	en_US
dc.subject	kinase	en_US
dc.title	Chronic myeloid leukemia associated with early lymphoblastic crisis	en_US
dc.type	Article	en_US